As of 2025-12-12, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (3.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -513.6%.
The range of the Relative Valuation is (1.44) - (5.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 13.7x | 8.6x |
| Forward P/E multiples | 3.5x - 13.9x | 8.7x |
| Fair Price | (1.44) - (5.68) | (3.58) |
| Upside | -266.9% - -755.9% | -513.6% |
| Date | P/E |